The New Selinexor Myeloma Community Support Group

MC EVENTS - January 26, 2021

The Myeloma Crowd Community is launching the first-ever online support group focused on a novel drug treatment—XPOVIO ® or selinexor—on Wed... Read More

American Society of Hematology Meeting Review: Register Now for the Myeloma Crowd Round Table Interactive Webcast on January 30

Six Myeloma Experts Discuss ASH Studies   Register Now   The American Society of Hematology (ASH) meeting is the most important scientific... Read More

A New Treatment Option for Relapsed Myeloma Targeting MAPK Signaling

A new treatment option for relapsed myeloma may be available via the MAPK signaling pathway.  Multiple myeloma patients learn all sorts of fancy ne... Read More

HealthTree University: Know Your Therapy (BETA) (Part 3 of 3)

HEALTHTREE - January 21, 2021

Editor’s note:  These videos are still in the editing stages, but they have important information about your disease and the myeloma therapies pat... Read More

Darzalex FASPRO Receives FDA Approval for AL Amyloidosis

MYELOMA NEWS - January 21, 2021

Darzalex FASPRO® (the subcuteneous injectable version of daratumumab) with bortezomib, cyclophosphamide and dexamethasone is now the first FDA-approved... Read More

Optimism for Federal Medical Research Support

MC NEWSROOM - January 21, 2021

President Biden’s past strong support for cancer research is inspiring cautious confidence among cancer advocates that medical and cancer research may bec... Read More

New Rules for Healthcare Costs Disclosure and Surprise Billing

MYELOMA COACH - January 20, 2021

In December, the Trump administration made two rules regarding medical costs disclosure as well as surprise billing: Healthcare Price Disclosure The healt... Read More

The Positive Effect of Consolidation Therapy in Multiple Myeloma

MYELOMA NEWS - January 18, 2021

It always interesting to talk to fellow multiple myeloma patients and learn about different treatment regimens and experiences they have had compared to ou... Read More

MCRT Webcast: High-Risk Disease Essentials

MC ROUND TABLES - January 16, 2021

High-risk disease poses the most difficult questions in myeloma treatment.  Increasing knowledge about genetics provides information about which targets to... Read More

Change is Possible: Achieve your Myeloma Goals in 2021 with the Help of a Myeloma Coach

MYELOMA COACH - January 15, 2021

The start of a brand new year feels fresh and inspiring. It's a clean slate, a new start. It’s no wonder that this is the time many commit to new... Read More

HealthTree University: Know Your Therapy (BETA) (Part 2 of 3)

HEALTHTREE - January 14, 2021

Editor’s note:  These videos are still in the editing stages, but they have important information about your disease and the myeloma therapies pat... Read More

Blood Type and Multiple Myeloma Outcomes

LIFE WITH MYELOMA - January 13, 2021

Does blood type matter when it comes to multiple myeloma? Turkish researchers shared new data in the Magazine of European Medical Oncology showing tha... Read More

Pesticide Use Linked to Myeloma Precursor Conditions

LIFE WITH MYELOMA - January 12, 2021

A recent study of male farmers shows that the use of certain types of pesticides are associated with the precursor condition of multiple myeloma called&nbs... Read More

Find Myeloma Help

Myeloma Financial Resource


Find financial resources like housing, prescription and patient assistance programs and other helpful links that will guide you through your myeloma care.

Myeloma Specialist


Patients who are seen by myeloma specialists live longer. Find a myeloma specialists closest to you and add them to your care team for your best outcomes.

Myeloma Clinical Trials


Find personally relevant treatment options and clinical trials at every stage of your myeloma with HealthTree and SparkCures.

Myeloma Coach


We're a team of myeloma patient and caregiver volunteers who can help you find and use the best myeloma resources so you can better navigate your myeloma care.

Thanks to our Myeloma Crowd Community sponsors: